Forvis Mazars Wealth Advisors’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $221K | Buy |
|
|||||
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $210K | Buy |
|
|||||
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $238K | Sell |
|
|||||
|
2024
Q2 | $247K | Hold |
|
|||||
|
2024
Q1 | $215K | Buy |
|
|||||
|
2023
Q4 | $204K | Sell |
|
|||||
|
2023
Q3 | $217K | Sell |
|
|||||
|
2023
Q2 | $267K | Buy |
|
|||||
|
2023
Q1 | $214K | Buy |
|
|||||
|
2022
Q4 | $207K | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $264K | Buy |
|
|||||
|
2022
Q1 | $245K | Sell |
|
|||||
|
2021
Q4 | $341K | Sell |
|
|||||
|
2021
Q3 | $542K | Buy |
|